ISO/IEC 17025 accredited laboratory testing. Certificate of Analysis with every order. QR code on every vial.
Amylin analog studied for appetite and metabolic research.
Cagrilintide is a long-acting amylin analog studied for appetite regulation, satiety signaling, and weight-management research. Amylin is a pancreatic hormone that works alongside insulin and plays a role in slowing gastric emptying, reducing food intake, and influencing brain-based appetite circuits. Cagrilintide is often studied alone and in combination with GLP-1 receptor agonists because amylin and GLP-1 pathways may affect appetite through complementary mechanisms. Researchers are especially interested in how cagrilintide affects meal size, hunger signaling, body-weight regulation, and metabolic outcomes when paired with other incretin-based compounds.
Your cart is empty.
Your Information